To ascertain whether this selection was dependent on IFNγ-signalling by B16 tumour cells, we created B16-OVA cell line expressing a IFNγR1 mutated on Y445A, which abolishes the STAT1 binding site25. The gene discussed is IFNGR1; the disease is neoplasm.